United States of America

Our lawyers are handling baby powder lawsuits in all 50 states in 2026. The talcum powder lawsuits against Johnson & Johnson have been ongoing for years. The lawsuits allege that prolonged use of talcum powder (or “talc”), the active ingredient in products such as Baby Powder and Shower to Shower, can cause ovarian cancer in some women.

This page provides an update on J&J talc powder litigation and discusses the settlement amounts in ovarian cancer lawsuits for victims.

Latest News on J&J Talc Powder Lawsuit Update 2026

The core claim in the Suboxone litigation is straightforward: plaintiffs allege that Indivior and related defendants knew, or should have known, that Suboxone film could cause severe dental damage, including tooth decay, enamel erosion, broken teeth, tooth loss, and expensive dental reconstruction. Plaintiffs contend the companies failed to warn patients and prescribing doctors until the FDA required a dental warning in 2022.

Our lawyers are still taking selected Suboxone tooth decay lawsuits in 2026. We are screening these cases more carefully than we did earlier in the litigation. We know more now and, from seeing literally thousands of cases, we have a tighter handle on what we think will generate a Suboxone settlement.

Talk to Us About a Suboxone Tooth Decay Lawsuit

Boston Scientific spinal cord stimulator lawsuits are moving forward and our lawyers are taking calls from victims with claims every day.

What are these cases about? In September 2026, the FDA announced a Class I recall involving certain Boston Scientific Infinion CX leads after the manufacturer reported 1,081 serious injuries. 

That is a huge number, and product injuries like this are notoriously underreported.   Patients are now bringing lawsuits alleging that the stimulators that were meant to make them feel better instead caused electrical shocks, burning sensations, lead failures, neurological injuries, and, for too many patients, more surgery.

Bard PowerPort lawsuits allege that defects in implanted port catheters can cause fractures, migration, blood clots, infections, embolisms, and other serious complications. Thousands of product liability lawsuits are now pending against Bard and its parent company, Becton Dickinson, in a federal multidistrict litigation in Arizona. After a long slog, these cases are now moving forward.

The first bellwether trial ended with a partial defense verdict and a deadlocked jury on the central design defect claim. The second trial, Divelbliss v. C.R. Bard, led to a $40 million verdict. It involved an alleged fracture of a silicone Groshong catheter. The third trial, Lattanzio, ended in a defense verdict on October 30, 2026, in a catheter infection case. Five bellwether trials are scheduled through February 2027. The early results have been very different, and our lawyers remain bullish on well-documented fracture, migration, and embolization cases.

This page provides the latest Bard PowerPort lawsuit updates, projected settlement amounts, and information about who may qualify to file a claim.

Our lawyers are handling AFFF firefighting foam lawsuits around the country.

This page provides the most recent news and updates on the AFFF firefighting foam class action lawsuit and our prediction of the settlement amounts that plaintiffs with AFFF cancer lawsuits can expect to receive. You will not get more updated news on the AFFF litigation anywhere else.

Our AFFF firefighting foam lawyers believe the defendants will settle most of these lawsuits this year (2026) before a single trial.  Why? They will follow the same pattern as the water contamination lawsuits they settled for billions of dollars.  In those cases, we saw the defendants’ apparent preference for settlement over the uncertainties of a trial.  This makes sense; the AFFF lawsuits are strong cases.

This page is for women considering filing a Depo-Provera lawsuit. Our lawyers provide the latest updates, explain the litigation and settlement process, and offer our assessment of potential Depo-Provera settlement amounts.

Scientific research has found a strong association between prolonged use of injectable medroxyprogesterone acetate, the active drug in Depo-Provera, and intracranial meningioma. Women who received Depo-Provera injections and were later diagnosed with a meningioma are filing lawsuits alleging that Pfizer and related companies failed to provide an adequate warning.

A spinal cord stimulator is an implantable medical device used to manage chronic pain, most often involving the back or spine. These systems are marketed as a way to reduce pain by interrupting nerve signals before they reach the brain. But for a growing number of patients, the device fails to help. It introduces new and sometimes permanent problems, including electrical shocks, burning pain, infections, lead migration, hardware failure, and repeat surgeries to reposition or remove equipment that was supposed to improve quality of life.

This page explains spinal cord stimulator lawsuits and why they are being filed nationwide. It focuses on what patients are alleging, how these devices have failed in real-world use, and why many of these cases go beyond ordinary medical malpractice claims. The most serious lawsuits do not center on a single surgical mistake. They examine how modern spinal cord stimulators were designed, tested, and approved, and whether patients were ever adequately warned about the risks that now recur repeatedly in medical records and FDA reports.

Many victims want to know what spinal cord stimulator settlement amounts will look like and how we think compensation will be calculated, assuming an ultimate settlement. Settlement amounts and payouts in these cases will depend on several factors, which we dig into more fully below.

Abbott spinal cord stimulator lawsuits are being filed by patients who say devices intended to relieve their chronic pain instead caused electrical shocks, burning sensations, worsening pain, neurological injuries, and additional surgery. Some patients say their stimulators failed after repeated reprogramming attempts. Others allege that the leads moved, that the system stopped delivering treatment, or that Abbott representatives became more involved in their medical care than they should have, putting Abbott’s interests ahead of the patients’ well-being.

That paragraph is a nutshell of what this litigation is about. The number of filed cases is low right now, but our lawyers believe this litigation will eventually involve thousands of claims. We are getting a lot of calls in these cases, and lawyers we work with are also reporting that they are developing huge inventories of these cases.

On October 2, 2026, the federal judicial panel created MDL No. 3194 to coordinate related Abbott cases for pretrial proceedings in the Northern District of Illinois. The cases are assigned to U.S. District Judge Lindsay C. Jenkins.

This page provides updates on Camp Lejeune lawsuits.

Our lawyers are still working to give the latest update on the litigation, even though we are no longer taking new cases. Why? Because there is little information out there, and we are staying with victims, including those we do not represent, until the end.

We recently reopened the comments below on October 19 to give you a chance to share your thoughts.

Contact Information